Skip to content

Abametapir

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: Ha44, xeglyze

OfmFDA approvedATC P03AX07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Abametapir is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 2020. DrugCentral lists 4 molecular targets, including HDAC6, CCR5 and CCR8. Recorded indications include Pediculosis capitis.

  • Approval status: ofm (first approved 2020 by the FDA).
  • Molecular targets: HDAC6, CCR5, CCR8 and CCR1 (4 listed in DrugCentral).
  • Indications: Pediculosis capitis.
  • ATC code: P03AX07 (Other ectoparasiticides, incl. scabicides).
  • Molecular formula: C12H12N2; molecular weight 184.24 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Pediculosis capitis

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Histone deacetylase 6HDAC6unknownIC50 5.99
C-C chemokine receptor type 5CCR5unknownEC50 5.64
C-C chemokine receptor type 8CCR8unknownEC50 5.12
C-C chemokine receptor type 1CCR1unknownEC50 4.80

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2020-07-24FDA—DR REDDYS LABS SA

ATC classification

ATC codeTherapeutic hierarchy
P03AX07ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS › ECTOPARASITICIDES, INCL. SCABICIDES › Other ectoparasiticides, incl. scabicides

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Abametapir is on its molecule page.

Molecular formulaC12H12N2
Molecular weight184.24 g/mol
CAS number1762-34-1
InChIKeyPTRATZCAGVBFIQ-UHFFFAOYSA-N
PubChem CID15664
CC1=CN=C(C=C1)C2=NC=C(C=C2)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Abametapir used for?

DrugCentral lists the following indications for Abametapir: Pediculosis capitis.

How does Abametapir work?

Its molecular targets in DrugCentral include HDAC6, CCR5, CCR8 and CCR1.

When was Abametapir first approved?

Abametapir was first approved by the FDA in 2020.

What is the chemical formula of Abametapir?

Abametapir has the molecular formula C12H12N2 and a molecular weight of 184.24 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval2020-07-24
AgencyFDA
Targets4
Indications1
FormulaC12H12N2
DrugCentral ID5403
Interactive profile